<DOC>
	<DOC>NCT01785446</DOC>
	<brief_summary>The purpose of this study is to: - determine the effect of dexmedetomidine on cisatracurium infusion requirements and sufentanil consumption. - analyze the cisatracurium infusion requirements and sufentanil consumption in different age groups.</brief_summary>
	<brief_title>Study of Cisatracurium and Sufentanil Consumption Using a Closed Loop Computer Control Infusion System</brief_title>
	<detailed_description />
	<mesh_term>Dexmedetomidine</mesh_term>
	<mesh_term>Sufentanil</mesh_term>
	<mesh_term>Atracurium</mesh_term>
	<mesh_term>Cisatracurium</mesh_term>
	<criteria>ASA status 1 and 2. Consent approval written and oral. Patients scheduled for elective abdominal surgery under general anesthesia. Patients with neuromuscular disorders. Patients with history of stroke, flaccid paralysis or other neurological disorders. Significant renal, hepatic or cardiac dysfunction. Consent refusal.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Dexmedetomidine</keyword>
	<keyword>Cisatracurion infusion</keyword>
	<keyword>Sufentanil</keyword>
	<keyword>Recovery Index</keyword>
	<keyword>Closed loop computer control system</keyword>
</DOC>